Moderna’s Omicron vaccine shows better immune response than COVID shots
Fox News
Moderna’s vaccine catered to the Omicron variant produced more antibodies than the company’s original COVID shot. About 31 million U.S. citizens have received an Omicron-tailored shot.
Moderna, however, said levels of neutralizing antibody response dropped nearly 5-fold against the emerging subvariant BQ.1.1 when compared with BA.4/5, in an analysis of about 40 participants, although the virus neutralizing activity still remained "robust".
More Related News